米国の製薬用ろ過市場予測　2024-2032年

KEY FINDINGS
The United States pharmaceutical filtration market growth is projected to evolve at a CAGR of 6.98% during the forecast period, 2024-2032. The growing adoption of single-use technologies, the expanding biopharmaceutical sector, and high R&D expenditure are among the factors propelling the market growth of the country.

MARKET INSIGHTS
The United States pharmaceutical filtration market is experiencing growth, driven by substantial research and development (R&D) investments. Essential for pharmaceutical manufacturing, filtration processes are evolving to meet stringent regulatory standards, benefiting from technological advancements such as nanofiltration and ultrafiltration, which enhance precision and cost-effectiveness. Collaborative partnerships between pharmaceutical entities and filtration technology providers are yielding bespoke solutions. Automation and artificial intelligence integration are optimizing operational efficiency. Market leaders, including Merck & CO INC and Pall Corporation, are spearheading innovations, reflecting the industry’s dynamism.
Emerging trends highlight a transition to single-use filtration systems, a sustainability focus, and specialized filtration for biopharmaceuticals. The market’s trajectory envisions sustained R&D emphasis on continuous manufacturing, addressing biopharmaceutical challenges, and adapting to global events like pandemics.

REPORT SYNOPSIS

COMPETITIVE INSIGHTS
Some of the leading companies in the market are GE Healthcare, 3M Company, Merck & Co Inc, Pall Corporation (Danaher Corporation), Thermo Fisher Scientific Inc, Coorstek Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of Contents

1. RESEARCH SCOPE & METHODOLOGY
   1.1. STUDY OBJECTIVES
   1.2. METHODOLOGY
   1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
   2.1. MARKET SIZE & ESTIMATES
   2.2. COUNTRY SNAPSHOT
   2.3. COUNTRY ANALYSIS
   2.4. SCOPE OF STUDY
   2.5. CRISIS SCENARIO ANALYSIS
   2.6. MAJOR MARKET FINDINGS
3. MARKET DYNAMICS
   3.1. KEY DRIVERS
   3.1.1. GROWING ADOPTION OF SINGLE-USE TECHNOLOGIES
   3.1.2. EXPANDING BIOPHARMACEUTICAL SECTOR
   3.1.3. HIGH R&D EXPENDITURE
   3.2. KEY RESTRAINTS
   3.2.1. MEMBRANE FOULING ISSUE.
   3.2.2. SUBSTANTIAL CAPITAL NEEDED FOR OPERATIONS
4. KEY ANALYTICS
   4.1. KEY MARKET TRENDS
   4.1.1. GROWING ADOPTION OF ADVANCED FILTRATION TECHNOLOGIES
   4.1.2. INCREASING FOCUS ON SUSTAINABILITY
   4.2. PESTLE ANALYSIS

4.2.1. POLITICAL

4.2.2. ECONOMICAL

4.2.3. SOCIAL

4.2.4. TECHNOLOGICAL

4.2.5. LEGAL

4.2.6. ENVIRONMENTAL
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. MARKET CONCENTRATION ANALYSIS
4.5. REGULATORY FRAMEWORK

5. MARKET BY PRODUCT
   5.1. MEMBRANE FILTERS
   5.1.1. MIXED CELLULOSE ESTER (MCE) MEMBRANE FILTERS
   5.1.2. COATED CELLULOSE ACETATE MEMBRANE FILTERS
   5.1.3. NYLON MEMBRANE FILTERS
   5.1.4. PTFE MEMBRANE FILTERS
   5.1.5. PVDF MEMBRANE FILTERS
   5.1.6. OTHER MEMBRANE FILTERS
   5.2. PREFILTER & DEPTH FILTER MEDIA
   5.3. CARTRIDGE & CAPSULES
   5.4. SINGLE-USE SYSTEMS
   5.5. FILTER HOLDERS
   5.6. FILTRATION ACCESSORIES
   5.7. OTHER PRODUCTS
6. MARKET BY TECHNIQUE TYPE
   6.1. MICROFILTRATION
   6.2. NANOFILTRATION
   6.3. ULTRAFILTRATION
   6.3.1. UF HOLLOW FIBER MEMBRANE MODULE
   6.3.2. OTHER ULTRAFILTRATION
   6.4. OTHER TECHNIQUES
7. MARKET BY APPLICATION
   7.1. FINAL PRODUCT PROCESSING
   7.1.1. STERILE FILTRATION
   7.1.2. PROTEIN PURIFICATION
   7.1.3. VACCINE AND ANTIBODY PROCESSING
   7.1.4. ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION
   7.1.5. OTHER FINAL PRODUCT PROCESSING
   7.2. RAW MATERIAL FILTRATION
   7.3. CELL SEPARATION
   7.4. WATER PURIFICATION
   7.4.1. UF HOLLOW FIBER MEMBRANE MODULE
   7.4.2. OTHER WATER PURIFICATIONS TYPES
   7.5. AIR PURIFICATION
8. COMPETITIVE LANDSCAPE
   8.1. KEY STRATEGIC DEVELOPMENTS
   8.1.1. LIST OF MERGERS & ACQUISITIONS
   8.1.2. LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
   8.1.3. LIST OF PARTNERSHIPS & AGREEMENTS
   8.1.4. LIST OF BUSINESS EXPANSIONS & DIVESTITURES
   8.2. COMPANY PROFILES
   8.2.1. 3M
   8.2.1.1. COMPANY OVERVIEW
   8.2.1.2. PRODUCTS
   8.2.1.3. STRENGTHS & CHALLENGES
   8.2.2. CANTEL MEDICAL CORPORATION
   8.2.2.1. COMPANY OVERVIEW
   8.2.2.2. PRODUCTS
   8.2.2.3. STRENGTHS & CHALLENGES
   8.2.3. COORSTEK INC
   8.2.3.1. COMPANY OVERVIEW
   8.2.3.2. PRODUCTS
   8.2.3.3. STRENGTHS & CHALLENGES
   8.2.4. GE HEALTHCARE
   8.2.4.1. COMPANY OVERVIEW
   8.2.4.2. PRODUCTS
   8.2.4.3. STRENGTHS & CHALLENGES
   8.2.5. GRAVER TECHNOLOGIES LLC
   8.2.5.1. COMPANY OVERVIEW
   8.2.5.2. PRODUCTS
   8.2.5.3. STRENGTHS & CHALLENGES
   8.2.6. MERCK & CO INC
   8.2.6.1. COMPANY OVERVIEW
   8.2.6.2. PRODUCTS
   8.2.6.3. STRENGTHS & CHALLENGES
   8.2.7. PALL CORPORATION (DANAHER CORPORATION)
   8.2.7.1. COMPANY OVERVIEW
   8.2.7.2. PRODUCTS
   8.2.7.3. STRENGTHS & CHALLENGES
   8.2.8. THERMO FISHER SCIENTIFIC INC
   8.2.8.1. COMPANY OVERVIEW
   8.2.8.2. PRODUCTS
   8.2.8.3. STRENGTHS & CHALLENGES

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – PHARMACEUTICAL FILTRATION
TABLE 2: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY MEMBRANE FILTERS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY MEMBRANE FILTERS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY TECHNIQUE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY ULTRAFILTRATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY ULTRAFILTRATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY FINAL PRODUCT PROCESSING, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY FINAL PRODUCT PROCESSING, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY WATER PURIFICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY WATER PURIFICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: LIST OF MERGERS & ACQUISITIONS
TABLE 17: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 18: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 19: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: MARKET CONCENTRATION ANALYSIS
FIGURE 4: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 5: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY MEMBRANE FILTERS, 2024-2032 (IN $ MILLION)
FIGURE 6: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, GROWTH POTENTIAL, BY MEMBRANE FILTERS, IN 2023
FIGURE 7: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY MIXED CELLULOSE ESTER (MCE) MEMBRANE FILTERS, 2024-2032 (IN $ MILLION)
FIGURE 8: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY COATED CELLULOSE ACETATE MEMBRANE FILTERS, 2024-2032 (IN $ MILLION)
FIGURE 9: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY NYLON MEMBRANE FILTERS, 2024-2032 (IN $ MILLION)
FIGURE 10: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY PTFE MEMBRANE FILTERS, 2024-2032 (IN $ MILLION)
FIGURE 11: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY PVDF MEMBRANE FILTERS, 2024-2032 (IN $ MILLION)
FIGURE 12: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY OTHER MEMBRANE FILTERS, 2024-2032 (IN $ MILLION)
FIGURE 13: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY PREFILTER & DEPTH FILTER MEDIA, 2024-2032 (IN $ MILLION)
FIGURE 14: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY CARTRIDGE & CAPSULES, 2024-2032 (IN $ MILLION)
FIGURE 15: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY SINGLE-USE SYSTEMS, 2024-2032 (IN $ MILLION)
FIGURE 16: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY FILTER HOLDERS, 2024-2032 (IN $ MILLION)
FIGURE 17: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY FILTRATION ACCESSORIES, 2024-2032 (IN $ MILLION)
FIGURE 18: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 19: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, GROWTH POTENTIAL, BY TECHNIQUE TYPE, IN 2023
FIGURE 20: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY MICROFILTRATION, 2024-2032 (IN $ MILLION)
FIGURE 21: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY NANOFILTRATION, 2024-2032 (IN $ MILLION)
FIGURE 22: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY ULTRAFILTRATION, 2024-2032 (IN $ MILLION)
FIGURE 23: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, GROWTH POTENTIAL, BY ULTRAFILTRATION, IN 2023
FIGURE 24: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY UF HOLLOW FIBER MEMBRANE MODULE, 2024-2032 (IN $ MILLION)
FIGURE 25: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY OTHER ULTRAFILTRATION, 2024-2032 (IN $ MILLION)
FIGURE 26: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY OTHER TECHNIQUES, 2024-2032 (IN $ MILLION)
FIGURE 27: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023
FIGURE 28: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY FINAL PRODUCT PROCESSING, 2024-2032 (IN $ MILLION)
FIGURE 29: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, GROWTH POTENTIAL, BY FINAL PRODUCT PROCESSING, IN 2023
FIGURE 30: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY STERILE FILTRATION, 2024-2032 (IN $ MILLION)
FIGURE 31: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY PROTEIN PURIFICATION, 2024-2032 (IN $ MILLION)
FIGURE 32: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY VACCINE AND ANTIBODY PROCESSING, 2024-2032 (IN $ MILLION)
FIGURE 33: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION, 2024-2032 (IN $ MILLION)
FIGURE 34: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY OTHER FINAL PRODUCT PROCESSING, 2024-2032 (IN $ MILLION)
FIGURE 35: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY RAW MATERIAL FILTRATION, 2024-2032 (IN $ MILLION)
FIGURE 36: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY CELL SEPARATION, 2024-2032 (IN $ MILLION)
FIGURE 37: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY WATER PURIFICATION, 2024-2032 (IN $ MILLION)
FIGURE 38: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, GROWTH POTENTIAL, BY WATER PURIFICATION, IN 2023
FIGURE 39: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY UF HOLLOW FIBER MEMBRANE MODULE, 2024-2032 (IN $ MILLION)
FIGURE 40: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY OTHER WATER PURIFICATIONS TYPES, 2024-2032 (IN $ MILLION)
FIGURE 41: UNITED STATES PHARMACEUTICAL FILTRATION MARKET, BY AIR PURIFICATION, 2024-2032 (IN $ MILLION)